Renal denervation in patients with chronic kidney disease: an approach using CO2 angiography

[1] Mancia G(2023)2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA) J Hypertens 41 1874-2071

[2] Kreutz R(2022)Renal denervation: basic and clinical evidence Hypertens Res 45 198-209

[3] Brunström M(2021)Efficacy and safety of renal denervation for hypertension in patients with chronic kidney disease: a meta-analysis Int J Hyperth 38 732-42

[4] Burnier M(2020)Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial Lancet 395 1444-51

[5] Grassi G(2017)Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial Lancet 390 2160-70

[6] Januszewicz A(2015)Validation of renal artery dimensions measured by magnetic resonance angiography in patients referred for renal sympathetic denervation Acad Radio 22 1106-14

[7] Katsurada K(2019)Renal sensory nerves increase sympathetic nerve activity and blood pressure in 2-kidney 1-clip hypertensive mice J Neurophysiol 122 358-67

[8] Shinohara K(2020)Renal sensory activity regulates the γ-aminobutyric acidergic inputs to the paraventricular nucleus of the hypothalamus in goldblatt hypertension Front Physiol 11 601237-73

[9] Aoki J(2020)Selective afferent renal denervation mitigates renal and splanchnic sympathetic nerve overactivity and renal function in chronic kidney disease-induced hypertension J Hypertension 38 765-23

[10] Nanto S(2016)Resting afferent renal nerve discharge and renal inflammation: elucidating the role of afferent and efferent renal nerves in deoxycorticosterone acetate salt hypertension Hypertension 68 1415-79

[1] Mancia G(2023)2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA) J Hypertens 41 1874-2071

[2] Kreutz R(2022)Renal denervation: basic and clinical evidence Hypertens Res 45 198-209

[3] Brunström M(2021)Efficacy and safety of renal denervation for hypertension in patients with chronic kidney disease: a meta-analysis Int J Hyperth 38 732-42

[4] Burnier M(2020)Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial Lancet 395 1444-51

[5] Grassi G(2017)Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial Lancet 390 2160-70

[6] Januszewicz A(2015)Validation of renal artery dimensions measured by magnetic resonance angiography in patients referred for renal sympathetic denervation Acad Radio 22 1106-14

[7] Katsurada K(2019)Renal sensory nerves increase sympathetic nerve activity and blood pressure in 2-kidney 1-clip hypertensive mice J Neurophysiol 122 358-67

[8] Shinohara K(2020)Renal sensory activity regulates the γ-aminobutyric acidergic inputs to the paraventricular nucleus of the hypothalamus in goldblatt hypertension Front Physiol 11 601237-73

[9] Aoki J(2020)Selective afferent renal denervation mitigates renal and splanchnic sympathetic nerve overactivity and renal function in chronic kidney disease-induced hypertension J Hypertension 38 765-23

[10] Nanto S(2016)Resting afferent renal nerve discharge and renal inflammation: elucidating the role of afferent and efferent renal nerves in deoxycorticosterone acetate salt hypertension Hypertension 68 1415-79